BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7772301)

  • 21. MS-271, a novel inhibitor of calmodulin-activated myosin light chain kinase from Streptomyces sp.--I. Isolation, structural determination and biological properties of MS-271.
    Yano K; Toki S; Nakanishi S; Ochiai K; Ando K; Yoshida M; Matsuda Y; Yamasaki M
    Bioorg Med Chem; 1996 Jan; 4(1):115-20. PubMed ID: 8689231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective calmodulin inhibition toward myosin light chain kinase by a new cerebral circulation improver, Ro 22-4839.
    Nakajima T; Katoh A
    Mol Pharmacol; 1987 Jul; 32(1):140-6. PubMed ID: 3037298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation and partial sequence of pregnant sheep myometrium myosin light chain kinase.
    Pato MD; Kerc E; Lye SJ
    Mol Cell Biochem; 1995; 149-150():59-69. PubMed ID: 8569750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.
    Hidaka H; Inagaki M; Kawamoto S; Sasaki Y
    Biochemistry; 1984 Oct; 23(21):5036-41. PubMed ID: 6238627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein kinase inhibitors and blood pressure control in spontaneously hypertensive rats.
    Buchholz RA; Dundore RL; Cumiskey WR; Harris AL; Silver PJ
    Hypertension; 1991 Jan; 17(1):91-100. PubMed ID: 1986986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and characterization of myosin light-chain kinase from the rat pancreas.
    Bissonnette M; Kuhn D; de Lanerolle P
    Biochem J; 1989 Mar; 258(3):739-47. PubMed ID: 2730565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mode of inhibition of smooth muscle myosin light chain kinase by synthetic peptide analogs of the regulatory site.
    Ikebe M
    Biochem Biophys Res Commun; 1990 Apr; 168(2):714-20. PubMed ID: 2334433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
    Hagiwara M; Inagaki M; Watanabe M; Ito M; Onoda K; Tanaka T; Hidaka H
    Mol Pharmacol; 1987 Jul; 32(1):7-12. PubMed ID: 2955213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effect of phosphorylated myosin light chain kinase on the ATP-dependent actin-myosin interaction.
    Samizo K; Okagaki T; Kohama K
    Biochem Biophys Res Commun; 1999 Jul; 261(1):95-9. PubMed ID: 10405329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calmodulin binding domains: characterization of a phosphorylation and calmodulin binding site from myosin light chain kinase.
    Lukas TJ; Burgess WH; Prendergast FG; Lau W; Watterson DM
    Biochemistry; 1986 Mar; 25(6):1458-64. PubMed ID: 3754463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of myosin light chain kinase, protein kinase A, and protein kinase C inhibition on porcine oocyte activation.
    Green KM; Kim JH; Wang WH; Day BN; Prather RS
    Biol Reprod; 1999 Jul; 61(1):111-9. PubMed ID: 10377038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The smooth muscle 132 kDa cyclic GMP-dependent protein kinase substrate is not myosin light chain kinase or caldesmon.
    Sarcevic B; Robinson PJ; Pearson RB; Kemp BE
    Biochem J; 1990 Oct; 271(2):493-9. PubMed ID: 2173564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanism of inhibition of light-chain phosphorylation by purealin in chicken gizzard myosin.
    Takito J; Ohizumi Y; Nakamura H; Kobayashi J; Ebisawa K; Nonomura Y
    Eur J Pharmacol; 1987 Oct; 142(2):189-95. PubMed ID: 2961581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent peptide inhibitors of smooth muscle myosin light chain kinase: mapping of the pseudosubstrate and calmodulin binding domains.
    Foster CJ; Johnston SA; Sunday B; Gaeta FC
    Arch Biochem Biophys; 1990 Aug; 280(2):397-404. PubMed ID: 2369131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of the native form of chicken gizzard myosin light-chain kinase.
    Ngai PK; Carruthers CA; Walsh MP
    Biochem J; 1984 Mar; 218(3):863-70. PubMed ID: 6326748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catalytic fragment of protein kinase C exhibits altered substrate specificity toward smooth muscle myosin light chain.
    Nakabayashi H; Sellers JR; Huang KP
    FEBS Lett; 1991 Dec; 294(1-2):144-8. PubMed ID: 1743284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Domain organization of chicken gizzard myosin light chain kinase deduced from a cloned cDNA.
    Guerriero V; Russo MA; Olson NJ; Putkey JA; Means AR
    Biochemistry; 1986 Dec; 25(26):8372-81. PubMed ID: 3030394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification, characterization and substrate specificity of calmodulin-dependent myosin light-chain kinase from bovine brain.
    Bartelt DC; Moroney S; Wolff DJ
    Biochem J; 1987 Nov; 247(3):747-56. PubMed ID: 3426560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of calmodulin-activated smooth-muscle myosin light-chain kinase by calmodulin-binding peptides and fluorescent (phosphodiesterase-activating) calmodulin derivatives.
    Török K; Cowley DJ; Brandmeier BD; Howell S; Aitken A; Trentham DR
    Biochemistry; 1998 Apr; 37(17):6188-98. PubMed ID: 9558358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinase inhibitors in plants of the myrtaceae, proteaceae, and leguminosae.
    Larkin M; Brazier J; Ternai B; Polya GM
    Planta Med; 1993 Dec; 59(6):525-8. PubMed ID: 17230363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.